EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Free Cash Flow (2010 - 2026)

EyePoint (EYPT) posted Free Cash Flow of -$80.6 million for Q1 2026, down 18.18% sequentially from -$68.2 million in Q4 2025, and down 51.7% YoY from -$167.0 million in Q1 2025.

Analysis

EyePoint (EYPT) Free Cash Flow (2010 - 2026) Analysis & Trends

EyePoint has reported Free Cash Flow for 17 years, with the latest figure at -$80.6 million in Q1 2026.

  • Quarterly Free Cash Flow fell 51.7% year-over-year to -$80.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$270.9 million (down 78.52% YoY) and the FY2025 annual result came in at -$243.4 million, down 86.82% from the prior year.
  • Free Cash Flow fell to -$80.6 million in Q1 2026 per EYPT's latest filing, from -$68.2 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $57.5 million in Q2 2023 and troughed at -$80.6 million in Q1 2026.
  • A 5-year average of -$30.6 million and a median of -$23.1 million in 2023 frame the typical range for Free Cash Flow.
  • The sharpest annual moves came in 2023 and 2025: Free Cash Flow jumped 397.33% in 2023, then plunged 215.19% in 2025.
  • Over 5 years, Free Cash Flow stood at -$13.2 million in 2022, then sank by 75.43% to -$23.1 million in 2023, then tumbled by 62.18% to -$37.5 million in 2024, then plunged by 82.08% to -$68.2 million in 2025, then slipped by 18.18% to -$80.6 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$80.6 million, -$68.2 million, and -$59.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -563.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -389.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 437.80 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 292.04 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 477.44 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -95.09 Mn
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00 -62.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -62.41 Mn
Mar 31, 2026 -83.91 Mn
Dec 31, 2025 -66.03 Mn
Sep 30, 2025 -60.15 Mn
Jun 30, 2025 -63.81 Mn
Mar 31, 2025 -53.40 Mn
Dec 31, 2024 -38.01 Mn
Sep 30, 2024 -40.60 Mn
Jun 30, 2024 -21.08 Mn
Mar 31, 2024 -32.37 Mn
Dec 31, 2023 -23.99 Mn
Sep 30, 2023 -16.92 Mn
Jun 30, 2023 56.63 Mn
Mar 31, 2023 -17.32 Mn
Dec 31, 2022 -13.17 Mn
Sep 30, 2022 -14.33 Mn
Jun 30, 2022 -19.34 Mn
Mar 31, 2022 -20.31 Mn
Dec 31, 2021 -16.67 Mn
Sep 30, 2021 -7.92 Mn